Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Identification and Pharmaceutical Characterization of a New Itraconazole Terephthalic Acid Cocrystal

R. Machado Cruz, T. Boleslavská, J. Beránek, E. Tieger, B. Twamley, MJ. Santos-Martinez, O. Dammer, L. Tajber,

. 2020 ; 12 (8) : . [pub] 20200806

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20021853

Grantová podpora
99999.001482/2015-07 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
12/RC/2275 Science Foundation Ireland - Ireland
12/RC/2275 European Regional Development Fund
778051 Horizon 2020 Framework Programme

The crystallization of poorly soluble drug molecules with an excipient into new solid phases called cocrystals has gained a considerable popularity in the pharmaceutical field. In this work, the cocrystal approach was explored for a very poorly water soluble antifungal active, itraconazole (ITR), which was, for the first time, successfully converted into this multicomponent solid using an aromatic coformer, terephthalic acid (TER). The new cocrystal was characterized in terms of its solid-state and structural properties, and a panel of pharmaceutical tests including wettability and dissolution were performed. Evidence of the cocrystal formation was obtained from liquid-assisted grinding, but not neat grinding. An efficient method of the ITR-TER cocrystal formation was ball milling. The stoichiometry of the ITR-TER phase was 2:1 and the structure was stabilized by H-bonds. When comparing ITR-TER with other cocrystals, the intrinsic dissolution rates and powder dissolution profiles correlated with the aqueous solubility of the coformers. The rank order of the dissolution rates of the active pharmaceutical ingredient (API) from the cocrystals was ITR-oxalic acid > ITR-succinic acid > ITR-TER. Additionally, the ITR-TER cocrystal was stable in aqueous conditions and did not transform to the parent drug. In summary, this work presents another cocrystal of ITR that might be of use in pharmaceutical formulations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20021853
003      
CZ-PrNML
005      
20230703090209.0
007      
ta
008      
201125s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/pharmaceutics12080741 $2 doi
035    __
$a (PubMed)32781726
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Machado Cruz, Ricardo $u School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.
245    10
$a Identification and Pharmaceutical Characterization of a New Itraconazole Terephthalic Acid Cocrystal / $c R. Machado Cruz, T. Boleslavská, J. Beránek, E. Tieger, B. Twamley, MJ. Santos-Martinez, O. Dammer, L. Tajber,
520    9_
$a The crystallization of poorly soluble drug molecules with an excipient into new solid phases called cocrystals has gained a considerable popularity in the pharmaceutical field. In this work, the cocrystal approach was explored for a very poorly water soluble antifungal active, itraconazole (ITR), which was, for the first time, successfully converted into this multicomponent solid using an aromatic coformer, terephthalic acid (TER). The new cocrystal was characterized in terms of its solid-state and structural properties, and a panel of pharmaceutical tests including wettability and dissolution were performed. Evidence of the cocrystal formation was obtained from liquid-assisted grinding, but not neat grinding. An efficient method of the ITR-TER cocrystal formation was ball milling. The stoichiometry of the ITR-TER phase was 2:1 and the structure was stabilized by H-bonds. When comparing ITR-TER with other cocrystals, the intrinsic dissolution rates and powder dissolution profiles correlated with the aqueous solubility of the coformers. The rank order of the dissolution rates of the active pharmaceutical ingredient (API) from the cocrystals was ITR-oxalic acid > ITR-succinic acid > ITR-TER. Additionally, the ITR-TER cocrystal was stable in aqueous conditions and did not transform to the parent drug. In summary, this work presents another cocrystal of ITR that might be of use in pharmaceutical formulations.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Boleslavská, Tereza $u Zentiva, k.s., U Kabelovny 130, 102 37 Prague, Czech Republic. Department of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague, Czech Republic.
700    1_
$a Beránek, Josef $u Zentiva, k.s., U Kabelovny 130, 102 37 Prague, Czech Republic.
700    1_
$a Tieger, Eszter $u Zentiva, k.s., U Kabelovny 130, 102 37 Prague, Czech Republic.
700    1_
$a Twamley, Brendan $u School of Medicine, Trinity College Dublin, Dublin 2, Ireland.
700    1_
$a Santos-Martinez, Maria Jose $u School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland. School of Chemistry, Trinity College Dublin, Dublin 2, Ireland.
700    1_
$a Dammer, Ondřej $u Zentiva, k.s., U Kabelovny 130, 102 37 Prague, Czech Republic. $7 xx0303489
700    1_
$a Tajber, Lidia $u School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.
773    0_
$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 12, č. 8 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32781726 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20230703090208 $b ABA008
999    __
$a ind $b bmc $g 1591562 $s 1112525
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 12 $c 8 $e 20200806 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
GRA    __
$a 99999.001482/2015-07 $p Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
GRA    __
$a 12/RC/2275 $p Science Foundation Ireland $2 Ireland
GRA    __
$a 12/RC/2275 $p European Regional Development Fund
GRA    __
$a 778051 $p Horizon 2020 Framework Programme
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...